With the development of medical science, the role of medical personnel is also increasing. Patient care requires: medical and technical knowledge, skills for mastering new skills, improving acquired knowledge. Innovation is a process in which an idea acquires economic content. Medical science is actively developing, its efforts directed at diseases that were previously considered incurable. Currently, one of its directions is "biologization" - a direction associated with molecular and cellular biology. Cell biology is regenerative medicine that uses products grown outside the body, as well as, modified human cells. Molecular biology is the direction of increasing the length of an individual's active life with the help of his or her body's capabilities. Also, the development of medicine takes place on the basis of biomedicine. A new direction in medicine is being created - translational medicine, the basis of which is molecular diagnostics. Innovative activity in developing countries related to the demand for medical services. Everyone wants to be healthy, and the higher the level of medicine, the higher the demand for it. Despite the fact that the level of modern medicine is quite high, but there is a demand for: improved medical technology, new methods of treatment, an improved management system, etc. This forces the improvement of scientific activity, i.e., innovative developments. However, innovative development is not a cheap event, and the budget of not every country can allocate a sufficient amount of funds for these developments. Countries with a stable economic situation allow allocating funds from the country's budget for the development of new technologies for healthcare. Which will undoubtedly lead to an increase in the level of medicine in the future, raising the standard of living of people and the economic level of the country. The cost of health care services grows due to the development of new technologies, and the economic growth of any country is determined by the amount of the population's spending on health care. Population growth leads to a cumulative increase in health care costs as the demand for vaccines and treatment increases. This direction is influenced by: the development of technologies related to monitoring the human condition. To predict the outcome of a patient's treatment, manufacturers of these technologies, are working to identify biomarkers, in order to successfully modify clinical trials with more accurate results. So that these trials are convenient and the time to implement them is shorter. The biomarker market continues to shape new research solutions. Each year, up to 80,000 deaths occur due to inadequate body response to medical drugs. Up to 2 million hospitalizations occur for the same reason. Therefore, genome decoding will enable quick identification of the causes of diseases, which will help to make the best choice of drugs for the patient, and reduce the cost of the procedure itself. Individualized medicine will allow diseases to be treated more effectively. And now it is one of the main directions of modern medicine, because the disease is easier to prevent than to treat, so scientists in all countries are working on new methods of detection, prevention. Prevention is a kind of intelligence. And reconnaissance is an integral part of military operations. The disease is the enemy, the patient is the command. The task of intelligence is to report to the command about the enemy's intentions before they are carried out. Thus, every person must have an idea of the state of his or her body in order to take prompt action, in case of suspicion, of any disease. The aging of the world's population is a major cause of disease. The rising cost of health care is related to the number of diseases a person has, which is known to increase as he or she gets older. By 2030, the number of elderly people in our country will be over 40%, with chronic disease treatment now accounting for up to 75% of all medical costs. The advent of "genetic diagnosis" will allow medicine to shift to preventing chronic diseases rather than treating them, thus significantly reducing costs. So, we need conditions for the introduction in practice of new forms of organization of medical care to the population, for the transition of the health care system to the standardization of medical care, as well as for the creation of a competitive market of medical services. All this requires the development of reasonable approaches to the formation of standards for the management of patients, the provision of medical care at all levels. Putting "on stream" high-tech medical services, creation of new medical centers will allow to reduce waiting times, to ensure the availability of high-tech types of medical care.